Your browser doesn't support javascript.
loading
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Zibelman, Matthew; MacFarlane, Alexander W; Costello, Kimberly; McGowan, Thomas; O'Neill, John; Kokate, Rutika; Borghaei, Hossein; Denlinger, Crystal S; Dotan, Efrat; Geynisman, Daniel M; Jain, Angela; Martin, Lainie; Obeid, Elias; Devarajan, Karthik; Ruth, Karen; Alpaugh, R Katherine; Dulaimi, Essel Al-Saleem; Cukierman, Edna; Einarson, Margret; Campbell, Kerry S; Plimack, Elizabeth R.
Afiliación
  • Zibelman M; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. matthew.zibelman@fccc.edu.
  • MacFarlane AW; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA.
  • Costello K; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • McGowan T; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • O'Neill J; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Kokate R; Office of Clinical Research, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Borghaei H; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Denlinger CS; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Dotan E; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Geynisman DM; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Jain A; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Martin L; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Obeid E; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Devarajan K; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ruth K; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Alpaugh RK; Protocol Support Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Dulaimi EA; Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Cukierman E; Cancer Signaling and Microenvironment Program, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Einarson M; High Throughput Screening Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Campbell KS; Immune Monitoring/Cell Sorting Facility, Institute for Cancer Research, Philadelphia, PA, USA.
  • Plimack ER; Department of Hematology Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Nat Commun ; 14(1): 4513, 2023 07 27.
Article en En | MEDLINE | ID: mdl-37500647
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Neoplasias Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Neoplasias Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos